Kimberly H Allison

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. doi PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Int J Gynecol Pathol 31:151-159. 2012
  2. doi Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, 1959 NE Pacific, Box 356100, Seattle, WA 98195, USA
    Appl Immunohistochem Mol Morphol 16:329-43. 2008
  3. pmc Diagnosing endometrial hyperplasia: why is it so difficult to agree?
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, Seattle, WA, USA
    Am J Surg Pathol 32:691-8. 2008
  4. ncbi Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?
    Kimberly H Allison
    Department of Anatomic Pathology, University of Washington Medical Center, Seattle, Washington 98195, USA
    Int J Gynecol Pathol 27:10-7. 2008
  5. ncbi Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast
    Kimberly H Allison
    Division of Anatomic Pathology, University of Washington Medical Center, 1959 NE Pacific St, Room BB 220, Box 356100, Seattle, WA 98195, USA
    Arch Pathol Lab Med 130:1875-7. 2006
  6. doi Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, Seattle, WA 98195, USA
    Hum Pathol 42:41-50. 2011
  7. ncbi Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases
    Kimberly H Allison
    Department of Pathology, University of Washington School of Medicine, Seattle, USA
    Arch Pathol Lab Med 128:1418-23. 2004
  8. pmc Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging
    Sana Parsian
    Departments of Radiology, University of Washington School of Medicine, Seattle Cancer Care Alliance, 825 Eastlake Ave E, G3 200, Seattle, WA 98109 1023, USA
    Radiology 265:696-706. 2012
  9. doi Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications
    Jennifer R Kohr
    Department of Radiology, University of Washington Medical Center, Seattle, Wash, USA
    Radiology 255:723-30. 2010
  10. pmc Biomarkers of progestin therapy resistance and endometrial hyperplasia progression
    Kristen Upson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Am J Obstet Gynecol 207:36.e1-8. 2012

Detail Information

Publications34

  1. doi PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Int J Gynecol Pathol 31:151-159. 2012
    ..However, it is not useful in distinguishing between these diagnostic categories...
  2. doi Immunohistochemical markers in endometrial hyperplasia: is there a panel with promise? A review
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, 1959 NE Pacific, Box 356100, Seattle, WA 98195, USA
    Appl Immunohistochem Mol Morphol 16:329-43. 2008
    ..The goal of this literature review was to identify studies on endometrial hyperplasia (EH) that describe markers with potential to predict response to progestin therapy or potential for progression to invasive disease...
  3. pmc Diagnosing endometrial hyperplasia: why is it so difficult to agree?
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, Seattle, WA, USA
    Am J Surg Pathol 32:691-8. 2008
    ..Although obtaining additional tissue may increase diagnostic reproducibility, differences in interpretation of key histologic features like cytologic atypia remain major factors contributing to diagnostic disagreement...
  4. ncbi Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?
    Kimberly H Allison
    Department of Anatomic Pathology, University of Washington Medical Center, Seattle, Washington 98195, USA
    Int J Gynecol Pathol 27:10-7. 2008
    ..5-cm borderline change...
  5. ncbi Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast
    Kimberly H Allison
    Division of Anatomic Pathology, University of Washington Medical Center, 1959 NE Pacific St, Room BB 220, Box 356100, Seattle, WA 98195, USA
    Arch Pathol Lab Med 130:1875-7. 2006
    ..The clinical behavior of this rare form of gestational trophoblastic disease is difficult to predict. Although most cases follow a benign course following resection, there is a potential for metastatic disease...
  6. doi Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, Seattle, WA 98195, USA
    Hum Pathol 42:41-50. 2011
    ..04). In conclusion, qualitative features of atypical ductal hyperplasia on core biopsy such as suspicion for ductal carcinoma in situ may help stratify patients at the highest risk for upgrade...
  7. ncbi Radiographically occult, diffuse intrasinusoidal hepatic metastases from primary breast carcinomas: a clinicopathologic study of 3 autopsy cases
    Kimberly H Allison
    Department of Pathology, University of Washington School of Medicine, Seattle, USA
    Arch Pathol Lab Med 128:1418-23. 2004
    ..Rarely, metastatic carcinoma can diffusely infiltrate hepatic sinusoids, a pattern of metastasis that may be missed on imaging studies, and can result in liver failure...
  8. pmc Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging
    Sana Parsian
    Departments of Radiology, University of Washington School of Medicine, Seattle Cancer Care Alliance, 825 Eastlake Ave E, G3 200, Seattle, WA 98109 1023, USA
    Radiology 265:696-706. 2012
    ..To evaluate the diffusion-weighted (DW) imaging characteristics of nonmalignant lesion subtypes assessed as false-positive findings at conventional breast magnetic resonance (MR) imaging...
  9. doi Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications
    Jennifer R Kohr
    Department of Radiology, University of Washington Medical Center, Seattle, Wash, USA
    Radiology 255:723-30. 2010
    ....
  10. pmc Biomarkers of progestin therapy resistance and endometrial hyperplasia progression
    Kristen Upson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Am J Obstet Gynecol 207:36.e1-8. 2012
    ..We sought to identify biomarkers associated with progestin therapy resistance and persistence/progression of endometrial hyperplasia...
  11. pmc Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy
    Susan D Reed
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 98115, USA
    Obstet Gynecol 116:365-73. 2010
    ..We evaluated women with complex and atypical endometrial hyperplasia, comparing those prescribed progestin with those not prescribed progestin...
  12. doi Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI
    Roberta M Strigel
    Department of Radiology, University of Washington Medical Center, Seattle, WA, USA
    AJR Am J Roentgenol 195:792-8. 2010
    ....
  13. doi Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?
    Peter R Eby
    Department of Radiology, University of Washington Medical Center, 1959 NE Pacific, Seattle, WA 98195, USA
    Ann Surg Oncol 15:3232-8. 2008
    ....
  14. pmc In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters
    Habib Rahbar
    Department of Radiology and Pathology, University of Washington, Seattle, WA 98109 1023, USA
    Radiology 263:374-82. 2012
    ..To develop a model incorporating dynamic contrast material-enhanced (DCE) and diffusion-weighted (DW) magnetic resonance (MR) imaging features to differentiate high-nuclear-grade (HNG) from non-HNG ductal carcinoma in situ (DCIS) in vivo...
  15. doi Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories
    Matthew S Pugliese
    Surgical Residency, Swedish Medical Center, 747 Broad Way, Seattle, WA 98122, USA
    Ann Surg Oncol 16:113-20. 2009
    ..However, the clinical significance of these categories is debated in the literature...
  16. doi Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy
    Christopher Loiselle
    Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA
    Acad Radiol 21:92-8. 2014
    ....
  17. doi Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy
    Mara H Rendi
    Department of Anatomic Pathology, University of Washington Medical Center, Seattle, WA, USA
    Ann Surg Oncol 19:914-21. 2012
    ..The surgical management of lobular in-situ neoplasia (LN) identified by core needle biopsy (CNB) is currently variable. Our institution has routinely excised LN on CNB since 2003, allowing for an unbiased assessment of upgrade rates...
  18. pmc Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS)
    Natalia V Oster
    Department of Medicine, University of Washington, Seattle, WA, USA
    BMC Womens Health 13:3. 2013
    ..We use the newly developed Guidelines for Reporting Reliability and Agreement Studies (GRRAS) as a basis to report these methods...
  19. doi Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge
    Peter R Eby
    Department of Radiology, University of Washington Medical Center, Seattle, WA, USA
    AJR Am J Roentgenol 192:229-34. 2009
    ....
  20. pmc The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations
    Barbara M Norquist
    Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA, USA
    Cancer 116:5261-71. 2010
    ..BRCA1 or BRCA2 (BRCA1/2)-mutated ovarian carcinomas may originate in the fallopian tube. The authors of this report investigated alterations in BRCA1/2 tubal epithelium to define the molecular pathogenesis of these carcinomas...
  21. doi Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer
    Chirag A Shah
    University of Washington Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Seattle, Washington 98195, USA
    Gynecol Oncol 109:215-9. 2008
    ..Forty percent of women with ovarian cancer have circulating free tumor DNA. We sought to determine if the tumor immune infiltrate varied based on tumor p53 mutation status or presence of circulating tumor DNA...
  22. pmc Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes
    Julie M Wu
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
    Clin Cancer Res 17:437-46. 2011
    ..The purpose of this study is to elucidate the basis of this stromal response--whether they are elicited by individual tumors or whether they represent an endogenous host reaction produced by the patient...
  23. pmc Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients
    Brenda F Kurland
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA
    EJNMMI Res 2:34. 2012
    ..abstract:..
  24. doi Frequency of HER2 heterogeneity by fluorescence in situ hybridization according to CAP expert panel recommendations: time for a new look at how to report heterogeneity
    Kimberly H Allison
    Department of Pathology, University of Washington Medical Center, Seattle, 98195, USA
    Am J Clin Pathol 136:864-71. 2011
    ..Further definition of optimal criteria with clinical relevance is needed before HER2 heterogeneity reporting is adopted in routine practice...
  25. ncbi Alternate molecular genetic pathways in ovarian carcinomas of common histological types
    Julia Willner
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195, USA
    Hum Pathol 38:607-13. 2007
    ..Mutations in p53, PIK3CA, PTEN, and CTNNB1 account for most EC tumors; most CC remain unexplained. EC/CC histology is a favorable prognostic factor...
  26. doi Achieving 95% cross-methodological concordance in HER2 testing: causes and implications of discordant cases
    Erin E Grimm
    University of Washington Medical Center, Seattle, WA 98195, USA
    Am J Clin Pathol 134:284-92. 2010
    ..Focusing on issues with HER2 immunohistochemical interpretation can improve concordance rates for immunohistochemically positive cases, but biologic reasons may explain some discordant immunohistochemically negative cases...
  27. ncbi Superficial malignant peripheral nerve sheath tumor: a rare and challenging diagnosis
    Kimberly H Allison
    Department of Anatomic Pathology, University of Washington Medical Center, Seattle, WA 98195, USA
    Am J Clin Pathol 124:685-92. 2005
    ..However, identification of a benign precursor or origin from a nerve may be the most definitive way to properly classify these rare lesions...
  28. doi Molecular pathology of breast cancer: what a pathologist needs to know
    Kimberly H Allison
    Dept of Pathology, University of Washington Medical Center, Seattle, WA 98195, USA
    Am J Clin Pathol 138:770-80. 2012
    ....
  29. ncbi Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer
    Matthew S Pugliese
    Department of Surgery, Comprehensive Breast Cancer Program, Swedish Cancer Institute, Seattle, WA, USA
    Am J Surg 192:516-9. 2006
    ..This study evaluates the accuracy of intraoperative imprint cytology (IC) for detecting SLN metastases...
  30. doi FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence
    Joshua Z Press
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195, USA
    Gynecol Oncol 120:296-9. 2011
    ..To characterize clinical features of vulvar Paget's disease, and examine the quantity of immunosuppressive regulatory T-cells in vulvar Paget's tissue...
  31. doi Diffusion tensor magnetic resonance imaging of the normal breast
    Savannah C Partridge
    Department of Radiology, University of Washington, Seattle, WA 98195, USA
    Magn Reson Imaging 28:320-8. 2010
    ..The objective of this study was to evaluate diffusion anisotropy of the breast parenchyma and assess the range and repeatability of diffusion tensor imaging (DTI) parameters in normal breast tissue...
  32. doi Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target
    Sandra D Bohling
    Department of Anatomic Pathology, University of Washington Medical Center, Seattle, WA 98195 6100, USA
    Mod Pathol 21:1527-32. 2008
    ..These results argue that regulatory T cells may play a role in inducing immune tolerance to higher grade, more aggressive breast carcinomas, and are a potential therapeutic target for these cancers...
  33. pmc Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer
    Jennifer M Specht
    Medical Oncology and Nuclear Medicine, Department of Medicine, University of Washington, Seattle, Washington 98109, USA
    Clin Cancer Res 16:2803-10. 2010
    ..This analysis examines tumor metabolism and perfusion by tumor subtype...
  34. ncbi Angiosarcoma involving the gastrointestinal tract: a series of primary and metastatic cases
    Kimberly H Allison
    Department of Anatomic Pathology, University of Washington Medical Center, Seattle, WA 98195, USA
    Am J Surg Pathol 28:298-307. 2004
    ..Immunohistochemistry with vascular markers, CK20, and S-100 protein may be helpful in differentiating angiosarcoma from carcinoma and melanoma...